National HPV Vaccination Program in Poland—Public Awareness, Sources of Knowledge, and Willingness to Vaccinate Children against HPV

Author:

Jankowski Mateusz1ORCID,Grudziąż-Sękowska Justyna1ORCID,Wrześniewska-Wal Iwona1,Tyszko Piotr23,Sękowski Kuba1,Ostrowski Janusz1ORCID,Gujski Mariusz4ORCID,Pinkas Jarosław1ORCID

Affiliation:

1. School of Public Health, Centre of Postgraduate Medical Education, 01-826 Warsaw, Poland

2. Department of Social Medicine and Public Health, Medical University of Warsaw, 02-007 Warsaw, Poland

3. Institute of Rural Health in Lublin, 20-090 Lublin, Poland

4. Department of Public Health, Medical University of Warsaw, 02-097 Warsaw, Poland

Abstract

Since 1 June 2023, a nationwide HPV vaccination program was implemented in Poland. This study aimed to identify factors associated with public awareness of the national HPV vaccination program among adults in Poland and willingness to vaccinate children against HPV. This cross-sectional study was carried out between 14 and 17 July 2023 among 1056 adults in Poland. A self-prepared questionnaire was used. Among the respondents, 51.3% had heard about the free HPV vaccination program. The major source of knowledge on the national HPV vaccination program was TV (62%). Only 31.9% of respondents correctly indicated girls and boys aged 12 and 13 as the HPV-vaccination-eligible population. Willingness to vaccinate children against HPV was declared by 63.3% of respondents. Female gender (OR: 1.42; 95% CI: 1.11–1.81; p < 0.01), age 35–64 years (p < 0.05), having higher education (OR: 1.43; 95% CI: 1.11–1.84; p < 0.01), and living in cities with more than 500,000 residents (OR: 1.51; 95% CI: 1.01–2.28; p < 0.05) were significantly associated with higher odds to hear about the national HPV vaccination program. Age 50 years and over (p < 0.05), having higher education (OR: 1.43; 95% CI: 1.09–1.88; p < 0.05), living in cities with more than 500,000 residents (OR: 1.80; 95% CI: 1.14–2.83; p < 0.05), and no children under 18 in the home (OR: 1.39; 95% CI: 1.01–1.89; p < 0.05) were significantly associated with willingness to vaccinate children against HPV.

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference31 articles.

1. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors;Arbyn;Cochrane Database Syst. Rev.,2018

2. Review of HPV-related diseases and cancers;Brianti;New Microbiol.,2017

3. Epidemiology and prevention of Human Papillomavirus;Manini;Ann. Ig.,2018

4. Human Papillomavirus: Screening, Testing, and Prevention;Quinlan;Am. Fam. Physician.,2021

5. National Cancer Institute (2023, July 20). HPV and Cancer, Available online: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3